Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

West Pharmaceutical Services (WST)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,685,809
  • Shares Outstanding, K 73,484
  • Annual Sales, $ 1,717 M
  • Annual Income, $ 206,900 K
  • 60-Month Beta 1.29
  • Price/Sales 5.07
  • Price/Cash Flow 27.77
  • Price/Book 6.36

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate 0.72
  • Number of Estimates 4
  • High Estimate 0.72
  • Low Estimate 0.71
  • Prior Year 0.70
  • Growth Rate Est. (year over year) +2.86%

Price Performance

See More
Period Period Low Period High Performance
1-Month
112.33 +5.23%
on 04/23/19
124.10 -4.75%
on 04/26/19
+6.04 (+5.39%)
since 04/22/19
3-Month
101.15 +16.86%
on 03/08/19
124.10 -4.75%
on 04/26/19
+13.92 (+13.35%)
since 02/22/19
52-Week
89.55 +31.99%
on 05/23/18
125.09 -5.51%
on 10/01/18
+28.09 (+31.17%)
since 05/22/18

Most Recent Stories

More News
Certara Appoints Dr. William F. Feehery as Chief Executive Officer

Certara(R) the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, announced today that it has appointed Dr. William F. Feehery...

WST : 118.20 (-0.28%)
ABC vs. WST: Which Stock Is the Better Value Option?

ABC vs. WST: Which Stock Is the Better Value Option?

ABC : 81.80 (+1.53%)
WST : 118.20 (-0.28%)
West Announces Third-Quarter Dividend and Participation in Upcoming Investor Conferences

West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that the Company's Board of Directors has approved a third-quarter...

WST : 118.20 (-0.28%)
West Pharmaceutical: 1Q Earnings Snapshot

EXTON, Pa. (AP) _ West Pharmaceutical Services Inc. (WST) on Thursday reported first-quarter earnings of $55.4 million.

WST : 118.20 (-0.28%)
West Pharmaceut Falls 1.40% on Heavy Volume: Watch For Potential Rebound

West Pharmaceut (NYSE:WST) traded in a range yesterday that spanned from a low of $110.03 to a high of $111.31. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $111.14...

WST : 118.20 (-0.28%)
Report: Developing Opportunities within Navient, Avis Budget Group, ViewRay, Apollo Commercial Real Estate Finance, West Pharmaceutical Services, and Myomo -- Future Expectations, Projections Moving into 2019

In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Navient Corporation (NASDAQ:NAVI),...

NAVI : 13.22 (-2.58%)
MYO : 0.94 (-4.45%)
CAR : 30.31 (-3.56%)
ARI : 18.57 (-0.59%)
WST : 118.20 (-0.28%)
VRAY : 8.60 (-0.92%)
West Named as a Philadelphia Business Journal 2019 Faces of Philanthropy Honoree

West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the Company's recognition by the Philadelphia Business Journal...

WST : 118.20 (-0.28%)
West to Host First-Quarter 2019 Conference Call

West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release first-quarter 2019 financial results before...

WST : 118.20 (-0.28%)
SmarTrend Watching for Potential Pullback in Shares of West Pharmaceut After 1.12% Gain

West Pharmaceut (NYSE:WST) traded in a range yesterday that spanned from a low of $113.42 to a high of $114.50. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of...

WST : 118.20 (-0.28%)
West Expands Presence in Korea with New Sales Office

West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced it has expanded its presence in the Asia Pacific region with...

WST : 118.20 (-0.28%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade WST with:

Business Summary

West Pharmaceutical Services, Inc. is a global drug delivery technology company that applies proprietary materials science, formulation research and manufacturing innovation to advance the quality, therapeutic value, development speed and rapid market availability of pharmaceuticals, biologics, vaccines...

See More

Key Turning Points

2nd Resistance Point 119.71
1st Resistance Point 118.95
Last Price 118.20
1st Support Level 117.49
2nd Support Level 116.79

See More

52-Week High 125.09
Last Price 118.20
Fibonacci 61.8% 111.51
Fibonacci 50% 107.32
Fibonacci 38.2% 103.13
52-Week Low 89.55

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar